 |
 |
thanks so much, ray, for providing this update. i see duke is a participating location On 8/24/2018 12:52 PM, Rayilyn Brown wrote: > I have trouble spelling “nilotinib” - this was the cancer drug that helped PWP in Phase 1 trial. > > https://parkinsonsnewstoday.com/2018/08/24/phase-2-trial-shows-nilotinib-potential-to-modulate-dopamine-in-parkinsons-patients/?utm_source=PAR+E-mail+List&utm_campaign=90634ed8c2-RSS_WEEKLY_EMAIL_CAMPAIGN_DAILY_US&utm_medium=email&utm_term=0_62dd4fb5e3-90634ed8c2-71666077 > Ray > Rayilyn Brown > Past Director AZNPF > Arizona Chapter National Parkinson Foundation > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: mailto:[log in to unmask] > In the body of the message put: signoff parkinsn > ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn